Founded in 2001 as a spin-out venture company from Hokkaido University. We have been exploring a new business opportunities by providing a healthcare solution for the therapeutic area where a current solution is insufficient. In 2018, GTS announced “GTS 3.0 – Biotech Engineering Company, striving for value creation”, which targeted the pediatric disease as a core business in addition to the areas which GTS has been engaging till today such as the orphan disease and intractable disease. The aim is to provide patients as well as families and caregivers with the comprehensive healthcare solutions by the development of new drugs and therapeutic solutions.